Australia markets close in 1 hour 25 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
350.63-0.53 (-0.15%)
At close: 04:00PM EST
347.50 -3.13 (-0.89%)
After hours: 07:48PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 90.49B
Enterprise value 79.30B
Trailing P/E 26.36
Forward P/E 22.17
PEG ratio (5-yr expected) 0.50
Price/sales (ttm)9.47
Price/book (mrq)5.48
Enterprise value/revenue 8.21
Enterprise value/EBITDA 17.57

Trading information

Stock price history

Beta (5Y monthly) 0.42
52-week change 312.62%
S&P500 52-week change 316.58%
52-week high 3387.42
52-week low 3282.21
50-day moving average 3360.61
200-day moving average 3340.27

Share statistics

Avg vol (3-month) 31.22M
Avg vol (10-day) 31.31M
Shares outstanding 5257.68M
Implied shares outstanding 6257.68M
Float 8256.98M
% held by insiders 10.17%
% held by institutions 196.55%
Shares short (14 Nov 2023) 42.51M
Short ratio (14 Nov 2023) 41.79
Short % of float (14 Nov 2023) 40.97%
Short % of shares outstanding (14 Nov 2023) 40.97%
Shares short (prior month 12 Oct 2023) 42.86M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 323 Aug 2000

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin 35.94%
Operating margin (ttm)43.93%

Management effectiveness

Return on assets (ttm)14.34%
Return on equity (ttm)23.49%

Income statement

Revenue (ttm)9.65B
Revenue per share (ttm)37.49
Quarterly revenue growth (yoy)6.40%
Gross profit (ttm)5.32B
Net income avi to common (ttm)3.47B
Diluted EPS (ttm)13.29
Quarterly earnings growth (yoy)11.30%

Balance sheet

Total cash (mrq)11.93B
Total cash per share (mrq)46.29
Total debt (mrq)744.7M
Total debt/equity (mrq)4.51%
Current ratio (mrq)4.08
Book value per share (mrq)64.05

Cash flow statement

Operating cash flow (ttm)4.38B
Levered free cash flow (ttm)3.92B